Add time:09/08/2019 Source:sciencedirect.com
An experimental model resembling the “locked-lung syndrome” in humans has been produced in dogs, and the efficacy of soterenol, a new bronchodilator agent, has been studied. In a group of dogs in which isoproterenol was either ineffective or caused bronchoconstriction, soterenol, administered intravenously, intraduodenally, or given as an aerosol, effectively reduced bronchial airway resistance. A possible adverse action of isoproterenol on CO2 retention, which was corrected by soterenol, and other mechanisms which may be involved in producing a refractory state to isoproterenol have been discussed.
We also recommend Trading Suppliers and Manufacturers of Soterenol (cas 13642-52-9). Pls Click Website Link as below: cas 13642-52-9 suppliers
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View